AAAAAA

   
Results: 1-4 |
Results: 4

Authors: Kruse, CA Rubinstein, D
Citation: Ca. Kruse et D. Rubinstein, Cytotoxic T-lymphocytes reactive to patient major histocompatibility complex proteins for therapy of brain tumors, BRAIN TUMOR IMMUNOTHERAPY, 2001, pp. 149-170

Authors: Kruse, CA Lamb, C Hogan, S Smiley, WR Kleinschmidt-DeMasters, BK Burrows, FJ
Citation: Ca. Kruse et al., Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms, CANC GENE T, 7(1), 2000, pp. 118-127

Authors: Kruse, CA Visonneau, S Kleinschmidt-DeMasters, BK Gup, CJ Gomez, GG Paul, DB Santoli, D
Citation: Ca. Kruse et al., The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: Implications for local adoptive immunotherapy, CANCER RES, 60(20), 2000, pp. 5731-5739

Authors: Kleinschmidt-DeMasters, BK Orr, EA Savelieva, E Owens, GC Kruse, CA
Citation: Bk. Kleinschmidt-demasters et al., Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostainingin gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression, J NEURO-ONC, 41(1), 1999, pp. 31-42
Risultati: 1-4 |